Replimune News, Replimune Quote, REPL Quote

Replimune (NQ:REPL) Delayed: 8.07 +1.03 (14.63%)

Prev. Close

$7.04

Today 6M 1Y 5Y

Open

$6.90

52 Wk High

$1.45

52 Wk Low

$0.50

Day High

$8.10

Day Low

$6.81

P/E

N/A

EPS

$0.00

Volume

3,080,116

Friends, Peers and Foes (?): ANRO, LAZR, RXST, FLYW, SOC (more...)

ALERTS | RSS

Mar 2, 2026 05:31 PM Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Mar 2, 2026 08:00 AM Replimune to Present at Two Upcoming Investor Conferences
Feb 20, 2026 04:16 PM Form 4 Replimune Group, Inc. For: Feb 18 Filed by: Astley-Sparke Philip
Feb 17, 2026 08:28 AM Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: Forbion Capital Fund III Cooperatief U.A.
Feb 5, 2026 08:45 AM Replimune Group (REPL) PT Raised to $14 at Piper Sandler
Feb 4, 2026 06:54 AM Replimune Group, Inc. (REPL) Misses Q3 EPS by 1c
Feb 3, 2026 08:12 AM Form 10-Q Replimune Group, Inc. For: Dec 31
Feb 3, 2026 08:06 AM Form 8-K Replimune Group, Inc. For: Feb 03
Feb 3, 2026 08:00 AM Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Jan 12, 2026 08:01 AM Form 8-K Replimune Group, Inc. For: Jan 12

Entities mentioned with REPL

View All Entities